Lattice Biologics Ltd
Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstru… Read more
Lattice Biologics Ltd (LBLTF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2021: 0.021x
Based on the latest financial reports, Lattice Biologics Ltd (LBLTF) has a cash flow conversion efficiency ratio of 0.021x as of June 2021.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.13K) by net assets ($100.74K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lattice Biologics Ltd - Cash Flow Conversion Efficiency Trend (2000–2020)
This chart illustrates how Lattice Biologics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lattice Biologics Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lattice Biologics Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Finger Story Co. Ltd.
KO:417180
|
N/A |
|
VICCO
VN:HVT
|
N/A |
|
ADITYA BIRLA LIFESTYLE BRANDS LTD
NSE:ABLBL
|
N/A |
|
Zonzia Media Inc
PINK:ZONX
|
0.116x |
|
Hankook Steel Co. Ltd.
KQ:025890
|
N/A |
|
RANK GROUP (RNKA.SG)
STU:RNKA
|
N/A |
|
POSTNL (TNTC.SG)
STU:TNTC
|
-0.163x |
|
Ping An Guangzhou Comm Invest Guanghe Expressway
SHE:180201
|
N/A |
Annual Cash Flow Conversion Efficiency for Lattice Biologics Ltd (2000–2020)
The table below shows the annual cash flow conversion efficiency of Lattice Biologics Ltd from 2000 to 2020.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2020-09-30 | $-6.40 Million | $536.15K | -0.084x | -227.14% |
| 2019-09-30 | $-6.31 Million | $161.63K | -0.026x | +48.40% |
| 2018-09-30 | $-5.32 Million | $264.09K | -0.050x | -128.32% |
| 2017-09-30 | $-4.26 Million | $-746.95K | 0.175x | -51.58% |
| 2016-09-30 | $-5.89 Million | $-2.13 Million | 0.362x | -23.40% |
| 2015-09-30 | $-3.89 Million | $-1.84 Million | 0.472x | +701.63% |
| 2014-09-30 | $-476.65K | $-28.09K | 0.059x | -68.96% |
| 2013-09-30 | $-363.39K | $-69.00K | 0.190x | -92.22% |
| 2012-09-30 | $-58.04K | $-141.61K | 2.440x | +219.31% |
| 2011-09-30 | $264.94K | $-541.86K | -2.045x | -12446.94% |
| 2010-09-30 | $28.92 Million | $-471.37K | -0.016x | +35.15% |
| 2009-09-30 | $27.98 Million | $-703.13K | -0.025x | +58.42% |
| 2008-09-30 | $23.72 Million | $-1.43 Million | -0.060x | -105.18% |
| 2007-09-30 | $38.72 Million | $-1.14 Million | -0.029x | +35.13% |
| 2006-09-30 | $17.47 Million | $-793.61K | -0.045x | -0.75% |
| 2005-09-30 | $7.62 Million | $-343.32K | -0.045x | +61.63% |
| 2004-09-30 | $3.05 Million | $-358.84K | -0.117x | -58.82% |
| 2002-09-30 | $655.48K | $-48.49K | -0.074x | -130.47% |
| 2001-09-30 | $903.06K | $-28.99K | -0.032x | +67.97% |
| 2000-09-30 | $922.56K | $-92.45K | -0.100x | -- |